Site Map   Links   Investors  
The CompanyClinical TrialsPeopleNewsCareersDownloadContact  
TargeGen, Inc., formed in 2001, is a privately held biopharmaceutical company based in San Diego, CA. The company develops small molecule kinase inhibitors for the treatment of hematological malignancies and certain other disorders.
::Read More 
October 22nd
TargeGen Announces Successful Completion of Clinical Trial of JAK2 Inhibitor TG101348 in Myelofibrosis Patients
::Read More 
For more information, please see www.clinicaltrials.gov
::Read More 
 Site Information ©2004 TargeGen Inc.